ABSTRACT Cancer cells exhibit increased demand for glutamine-derived carbons to support anabolic processes. Indeed, the spectrum of glutamine-dependent tumors and the mechanisms through which glutamine supports cancer metabolism remain areas of active investigation. In the present study, we investigated the effects of glutamine deprivation on the correlation between tightening of tight junctions (TJs) and anti-invasive activity in human prostate carcinoma LnCap cells. Glutamine deprivation markedly inhibited cell motility and invasiveness in a time-dependent manner. The anti-invasive activity of glutamine deprivation was associated with an increased tightness of the TJ, which was demonstrated by an increase in transepithelial electrical res...
Nucleotide pools need to be constantly replenished in cancer cells to support cell proliferation. Th...
Nucleotide pools need to be constantly replenished in cancer cells to support cell proliferation. Th...
The microenvironment of solid tumors is a key determinant of therapy efficacy. The co-occurrence of ...
The role of glutaminolysis in providing metabolites to support tumour growth is well-established, bu...
Glutamine is conditionally essential in cancer cells, being utilized as a carbon and nitrogen source...
Cancer cells reprogram their metabolism to fulfil the rising bioenergetic demand due to the high pro...
Tumors are complex tissues composed of transformed epithelial cells as well as cancer-activated fibr...
Tumor ischemia participates in angiogenesis and cancer progression through cellular responses to hyp...
Purpose Resistance to androgen-deprivation therapies and progression to so-called castrate-resistant...
Within the tumour microenvironment (TME), there is a cellular 'tug-of-war' for glutamine, the most a...
Abstract Background Tumourigenic cells modify metabolic pathways in order to facilitate increased pr...
Glutamine metabolism has been proved to be dysregulated in many cancer cells, and is essential for p...
Nucleotide pools need to be constantly replenished in cancer cells to support cell proliferation. Th...
Glutamine can play a critical role in cellular growth in multiple cancers. Glutamine‐addicted cancer...
Alternative pathways of metabolism endowed cancer cells with metabolic stress. Inhibiting the relate...
Nucleotide pools need to be constantly replenished in cancer cells to support cell proliferation. Th...
Nucleotide pools need to be constantly replenished in cancer cells to support cell proliferation. Th...
The microenvironment of solid tumors is a key determinant of therapy efficacy. The co-occurrence of ...
The role of glutaminolysis in providing metabolites to support tumour growth is well-established, bu...
Glutamine is conditionally essential in cancer cells, being utilized as a carbon and nitrogen source...
Cancer cells reprogram their metabolism to fulfil the rising bioenergetic demand due to the high pro...
Tumors are complex tissues composed of transformed epithelial cells as well as cancer-activated fibr...
Tumor ischemia participates in angiogenesis and cancer progression through cellular responses to hyp...
Purpose Resistance to androgen-deprivation therapies and progression to so-called castrate-resistant...
Within the tumour microenvironment (TME), there is a cellular 'tug-of-war' for glutamine, the most a...
Abstract Background Tumourigenic cells modify metabolic pathways in order to facilitate increased pr...
Glutamine metabolism has been proved to be dysregulated in many cancer cells, and is essential for p...
Nucleotide pools need to be constantly replenished in cancer cells to support cell proliferation. Th...
Glutamine can play a critical role in cellular growth in multiple cancers. Glutamine‐addicted cancer...
Alternative pathways of metabolism endowed cancer cells with metabolic stress. Inhibiting the relate...
Nucleotide pools need to be constantly replenished in cancer cells to support cell proliferation. Th...
Nucleotide pools need to be constantly replenished in cancer cells to support cell proliferation. Th...
The microenvironment of solid tumors is a key determinant of therapy efficacy. The co-occurrence of ...